Opioid Prescriber Training: US FDA Still Debating Mandate; CMS Policies Having Impact Now
Even after convening a two-day meeting with speakers from across the health care sector to discuss how opioid prescriber education can be improved, FDA doesn’t seem any closer to determining how to mandate training – but there are some reasons to be optimistic about a 'culture' change nevertheless.
You may also be interested in...
Treatment guidelines may also appear in opioid labeling, and insurers seem to be taking the agency's advice, but will it be enough to satisfy Congress?
Pricing of anti-addiction therapies could come under more pressure from HHS if Trump Administration accepts White House commission recommendation to declare public health emergency on opioid crisis.
Appropriations bill report includes language stating that it is 'imperative' the agency take all steps necessary to require opioid prescriber training.